National Evidence-Based Guideline on Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes: Technical Report
Buckley, L, Docter, S, Morona, J, Juneja, V, Reddin, E, Mnatzaganian, G. Merlin, T
Record ID 32018000673
English
Authors' objectives:
1) To determine whether screening for macrovascular disease is effective 2) To determine which tools are effective in predicting secondary cardiovascular events 3) To determine if non-traditional risk factors should be measured 4) To determine if pharmacological lowering of blood pressure reduces secondary cardiovascular disease (CVD) events and if so how is that best achieved 5) To determine if pharmacological modification of lipids reduces secondary CVD events and if so, how is that best achieved 6) To determine if anti-platelet therapy reduces secondary CVD events and if so how is that best achieved 7) To determine if non-pharmacological interventions reduce secondary CVD events 8) To determine the cost-effectiveness of the identified interventions and assessments
Details
Project Status:
Completed
Year Published:
2015
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
Australia
MeSH Terms
- Diabetes Mellitus, Type 2
- Cardiovascular Diseases
- Cardiovascular Agents
- Diabetes Complications
- Diabetic Angiopathies
- Practice Guideline
- Secondary Prevention
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.